☰

Eric A. Voll, Ph.D. - Publications

Affiliations: 
2014 Life Sciences Northwestern University, Evanston, IL 
Area:
Cell Biology, Oncology
Tree Info Similar researchers PubMed Report error

7 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Xu L, Gordon R, Farmer R, Pattanayak A, Binkowski A, Huang X, Avram M, Krishna S, Voll E, Pavese J, Chavez J, Bruce J, Mazar A, Nibbs A, Anderson W, et al. Precision therapeutic targeting of human cancer cell motility. Nature Communications. 9: 2454. PMID 29934502 DOI: 10.1038/S41467-018-04465-5  0.672
2014 Pavese JM, Ogden IM, Voll EA, Huang X, Xu L, Jovanovic B, Bergan RC. Mitogen-activated protein kinase kinase 4 (MAP2K4) promotes human prostate cancer metastasis. Plos One. 9: e102289. PMID 25019290 DOI: 10.1371/Journal.Pone.0102289  0.76
2014 Voll EA, Ogden IM, Pavese JM, Huang X, Xu L, Jovanovic BD, Bergan RC. Heat shock protein 27 regulates human prostate cancer cell motility and metastatic progression. Oncotarget. 5: 2648-63. PMID 24798191 DOI: 10.18632/Oncotarget.1917  0.761
2012 Voll E, Ogden I, Huang X, Bergan R. Abstract 5331: The effect of heat shock protein 27 (HSP27) on prostate cancer cell adhesion, invasion and metastasis Cancer Research. 72: 5331-5331. DOI: 10.1158/1538-7445.Am2012-5331  0.783
2012 Xu L, Farmer R, Huang X, Pruell S, Voll E, Pavese J, Valsecchi M, Biddle M, Nibbs A, Avram M, Scheidt KA, Bergan RC. Abstract 4752: Selective inhibition of cancer metastasis with a novel small therapeutic molecule Cancer Research. 72: 4752-4752. DOI: 10.1158/1538-7445.Am2012-4752  0.778
2011 Xu L, Farmer R, Huang X, Valsecchi M, Pavese J, Voll E, Biddle M, Nibbs A, Pruell S, Avram M, Scheidt K, Bergan RC. Abstract C177: Chemical-driven biological probing: Discovery of a novel antimetastatic drug. Molecular Cancer Therapeutics. 10. DOI: 10.1158/1535-7163.Targ-11-C177  0.774
2010 Xu L, Farmer R, huang x, Pavese J, Voll E, Irene O, Biddle M, Nibbs A, Valsecchi M, Scheidt K, Bergan R. Abstract B58: Discovery of a novel drug KBU2046 that inhibits conversion of human prostate cancer to a metastatic phenotype Cancer Prevention Research. 3. DOI: 10.1158/1940-6207.Prev-10-B58  0.781
Show low-probability matches.